Interim analysis of NCT02458716: Feasibility of cytoreductive prostatectomy in men newly diagnosed with metastatic prostate cancer.

被引:0
|
作者
Yuh, Bertram E.
Kwon, Young Suk
Shinder, Brian
Kim, Sinae
Lee, Nara
Ruel, Nora
机构
关键词
D O I
10.1200/JCO.2017.35.6_suppl.e578
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e578
引用
收藏
页数:2
相关论文
共 50 条
  • [11] The role of cytoreductive radical prostatectomy (cRP) in men with hormone-sensitive, metastatic prostate cancer (mPCA)
    Heidenreich, Axel
    Fossati, Nicola
    Suardi, Nazareno
    Montorsi, Francesco
    Karnes, Jeffrey
    Shariat, Shahrokh F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [12] Preliminary results from a phase II trial of docetaxel before castration with degarelix in men with newly diagnosed metastatic prostate cancer.
    Gourdin, Theodore Stewart
    Lilly, Michael B.
    Hussain, Arif
    Savage, Stephen
    Clarke, Harry S.
    Sion, Amy Marie
    Grubb, Robert
    Sellman, David
    Dincman, Toros
    Mikoll, Jennifer
    Patel, Pooja
    Marshall, David T.
    Li, Hong
    Keane, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [13] Radiotherapy (RT) to the primary tumour for men with newly- diagnosed metastatic prostate cancer (PCa): Survival results from STAMPEDE (NCT00268476)
    Parker, Christopher C.
    James, Nicholas D.
    Brawley, Chris
    Clarke, Noel W.
    Attard, Gerhardt
    Chowdhury, Simon
    Cross, Bill
    Gilson, Clare
    Jones, Robert J.
    Millman, Robin
    Dearnaley, David P.
    Mason, Malcolm D.
    Ritchie, Alastair
    Russell, J. Martin
    Ali, Syed Adnan
    Eswar, Chinnamani
    Gale, Joanna
    Hoyle, Alex
    Lester, Jason
    Sheehan, Denise
    Tran, Anna
    Gillessen, Silke
    Amos, Claire
    Parmar, Mahesh K. B.
    Sydes, Matthew R.
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 37 - 37
  • [14] Reducing decisional conflict in men making treatment decisions on newly diagnosed localized prostate cancer.
    Johnson, David C.
    Wallen, Eric
    Smith, Angela
    Woods, Michael
    Pruthi, Raj
    Mueller, Dana
    Nielsen, Matthew Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [15] Personal preferences and treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
    Bosco, Jaclyn Lee Fong
    Halpenny, Barbara
    Berry, Donna Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [16] The feasibility of expectant management with inner-city men with newly diagnosed localized prostate cancer
    Anai, Satoshi
    Nakamura, Kogenta
    Chang, Myron
    Pendleton, John
    Yacoub, Saif
    Rosser, Charles J.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2008, 19 (01) : 164 - 170
  • [17] Adverse association of allostatic load with overall survival in men with newly diagnosed metastatic prostate cancer
    Sheean, P.
    Bolouri, M.
    O'connor, P.
    Wozniak, A.
    Joyce, C.
    Badami, A.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 : 94 - 95
  • [18] Cost-Effectiveness of Prostate Radiation Therapy in Men with Newly Diagnosed Low Burden Metastatic Prostate Cancer
    Lester-Coll, N. H.
    Ades, S.
    Yu, J. B.
    Atherly, A.
    Wallace, H. J.
    Sprague, B. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S180 - S181
  • [19] Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
    Rusthoven, Chad G.
    Jones, Bernard L.
    Flaig, Thomas W.
    Crawford, E. David
    Koshy, Matthew
    Sher, David J.
    Mahmood, Usama
    Chen, Ronald C.
    Chapin, Brian F.
    Kavanagh, Brian D.
    Pugh, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (24) : 2835 - +
  • [20] Presurgical sunitinib in patients with newly diagnosed metastatic renal cell carcinoma (mRCC): Interim toxicity and feasibility analysis
    Jonasch, E.
    Wood, C. G.
    Pagliaro, L. C.
    Corn, P. G.
    Aparicio, A.
    Marcott, V. D.
    Matin, S. F.
    Tannir, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)